| 상품명칭 |
Cyproconazol |
| 별명 |
(2rs,3rs; 2rs,3sr)-2-(4-chloro-phenyl)-3-cyclopropyl-1-(1h-1,2,4-triazol-1-yl; 4-triazole-1-ethanol,alpha-(4-chlorophenyl)-alpha-(1-cyclopropylethyl)-1h-2; alpha-(4-chlorophenyl)-alpha-(1-cyclopropylethyl)-1h-1,2,4-triazole-1-ethano; SHANDON; ALTO; 2RS,3RS)-2-(4-chlorophenyl)-3-cycloproyl-1-(1H-1,2,4-triazol-1-yl)butan-2-ol; Cyproconazole; 2-(4-Chlorophenyl)-3-cyclopropyl-1-(1,2,4-triazol-1-yl)butan-2-ol; 2-(4-chlorophenyl)-3-cyclopropyl-1-(1H-1,2,4-triazol-1-yl)butan-2-ol; 2-(4-chlorophenyl)-3-cyclopropyl-2-(1H-1,2,4-triazol-1-yl)butan-1-ol |
| 분자식 |
C15H18ClN3O |
| 분자량 |
291.7759 |
| InChI |
InChI=1/C15H18ClN3O/c1-11(12-2-3-12)15(8-20,19-10-17-9-18-19)13-4-6-14(16)7-5-13/h4-7,9-12,20H,2-3,8H2,1H3 |
| cas번호 |
113096-99-4;94361-06-5 |
| 분자 구조 |
|
| 밀도 |
1.32g/cm3 |
| 비등점 |
471.8°C at 760 mmHg |
| 굴절 지수 |
1.646 |
| 인화점 |
239.1°C |
| 위험성 표시 |
 Xn:Harmful;
|
| 리스크 규칙 |
R22:;
|
| 보안 규칙 |
S36:;
|
|
